Rating Change
Wells Fargo analysts reiterated a Equal-Weight rating on Bio-Rad Laboratories, Inc. (NYSE:BIO-B) on August 05, 2026.
reiterateNYSE:BIO-B
Wells Fargo Reiterates Equal-Weight Rating on Bio-Rad Laboratories, Inc. (BIO-B)
Rating Change Wells Fargo analysts reiterated a Equal-Weight rating on Bio-Rad Laboratories, Inc. (NYSE:BIO-B) on August 05, 2026. Market Context Bio-Rad Laboratories, Inc.
Market Context
Bio-Rad Laboratories, Inc. operates in the Healthcare sector. The stock currently trades at $337.00 with a market capitalization of $8.4B.
Analyst coverage from Wells Fargo provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Bio-Rad Laboratories, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Bio-Rad Laboratories, Inc.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 05, 2026 | Wells Fargo | Equal-Weight | N/A |
| Aug 05, 2026 | RBC Capital | Outperform | N/A |
| Aug 05, 2026 | Citigroup | Neutral | N/A |
| May 15, 2026 | RBC Capital | Outperform | N/A |
| May 01, 2026 | Wells Fargo | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View BIO-B Stock Page
Frequently Asked Questions
What does a Equal-Weight rating mean for BIO-B?
A Equal-Weight rating from Wells Fargo reflects the analyst's outlook on Bio-Rad Laboratories, Inc. (NYSE:BIO-B). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the BIO-B forecast page.
